뉴스/Concert Pharmaceuticals Says its Alopecia Areata Investigational…Concert Pharmaceuticals Says its Alopecia Areata Investigational Drug CTP-543 Met Phase 3 Trial Endpoints2022년 5월 23일11:44 UTCCCNCE